Clinical Trial: Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: STEMI
Study Type: OBSERVATIONAL
Official Title: Antiplatelets and Hemorrhagic MI
Brief Summary:
The MIRON-PLATELET study is a retrospective, observational multi-center analysis assessing the impact of different antiplatelet therapies on hemorrhagic myocardial infarction (HMI) incidence and outcomes in STEMI patients.Key endpoints include hemorrhagic transformation, MACE, bleeding complications, and 30-day mortality.Findings will offer insights into the safety and clinical implications of antiplatelet therapy in high-risk patients.
Read more